Home›Stock Screener›EIKO Lifesciences

EIKO Lifesciences Share Price Today | Stock Price & EIKO Lifesciences Share Screener

EIKO Chemicals & Petrochemicals
Live Share Price BSE
₹49.68
▲ 0.45 (0.91%)
2026-11-19 00:00:00

As of November 19, 2026, the live EIKO Lifesciences share price (BSE: EIKO) is ₹49.68, up 0.91% from the previous close, with shares trading between ₹49.68 and ₹50.89 in today's trading session, and a 52-week range of ₹43.87–₹55.48. Track EIKO market capitalization to gauge the company's total market size. Use the EIKO Lifesciences stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today EIKO Lifesciences opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹18 and net income of ₹2, with EBITDA of ₹3, an operating margin of 13.0% and a profit margin of 11.1%.

EIKO Lifesciences Market Cap ₹74.71 Cr.
EIKO P/E Ratio (TTM) 12.40
EIKO Lifesciences P/B Ratio 1.02
EPS (TTM) ₹3.26
Dividend Yield -
Debt to Equity 0.06
EIKO 52 Week High ₹55.48
EIKO Lifesciences 52 Week Low ₹43.87
Operating Margin 13.00%
Profit Margin 11.11%
EIKO Revenue (TTM) ₹18.00
EBITDA ₹3.00
Net Income ₹2.00
Total Assets ₹89.00
Total Equity ₹70.00

EIKO Lifesciences Share Price Chart

Track the current stock price of EIKO Lifesciences with an interactive chart. Analyse EIKO share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete EIKO Lifesciences stock quote in one place.

The quote of ₹49.68 sits between the 52-week low of ₹43.87 and the 52-week high of ₹55.48, and the latest session moved 0.91% from the previous close.

EIKO Lifesciences Company Profile - Fundamental Screener

Screen EIKO Lifesciences company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for EIKO shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Chemicals sector and the Chemicals & Petrochemicals industry, and it trades under ISIN INE666Q01016.

Company Details

Classification

Sector Chemicals
Industry Chemicals & Petrochemicals
Sub-Sector Chemicals & Petrochemicals
Segment E

Identifiers and Leadership

ISIN INE666Q01016

EIKO Lifesciences Balance Sheet Screener

Screen EIKO balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹89, up from ₹66 in 2025.

Latest statistics put total assets at ₹89 and shareholder funds at ₹70, with a leverage ratio of 0.06.

Item 2026 2025 2020 2019 2018

Assets

Total Assets 89 66 12 9 11
Current Assets 0 0 0 0 0
Fixed Assets 22 23 2 2 2

Liabilities

Total Liabilities 0 0 0 0 0
Current Liabilities 4 3 2 0 1
Non-Current Liabilities 0 0 0 0 0

Shareholders' Equity

Total Equity 70 57 1 5 6
Share Capital 14 14 4 4 4
Reserves & Surplus 50 43 -1 1 2

EIKO Lifesciences Income Statement Screener - Profit & Revenue Analysis

Screen EIKO Lifesciences income statement and profit fundamentals. Analyze EIKO quarterly results. EIKO Lifesciences reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2026-Sept, revenue was ₹18 and net profit was ₹2, equal to earnings per unit of ₹0.93, at an operating margin of 13%.

In that period expenses were ₹16, interest cost ₹0 and tax ₹1. The next period listed, 2026-Jun, shows revenue of ₹17 and net profit of ₹2.

Item 2026-Sept 2026-Jun 2026-Mar 2025-Dec 2025-Sept 2025-Jun 2025-Mar 2024-Dec 2024-Sept 2024-Jun 2020-Sept 2020-Jun 2020-Mar 2019-Dec 2019-Sept

Revenue and Expenses

Revenue 18 17 19 12 12 11 12 8 8 11 1 1 1 3 4
Expenses 16 15 16 10 10 9 10 7 8 10 1 0 2 5 6

Operating Costs and Margins

EBITDA 3 2 2 2 2 2 2 1 1 1 0 0 -1 -1 -2
Operating Profit % 13.00% 12.00% 12.00% 16.00% 15.00% 14.00% 12.00% 9.00% 5.00% 4.00% -6.00% 25.00% -148.00% -42.00% -44.00%
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Interest 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0

Profit and Earnings

Profit Before Tax 2 2 2 2 2 2 2 1 0 1 0 0 -1 -2 -2
Tax 1 1 1 1 0 0 0 0 0 0 0 0 0 0 -1
Net Profit 2 2 2 1 1 1 1 0 0 0 0 0 -1 -1 -1
EPS 0.93 0.91 0.93 0.88 0.78 0.66 0.80 0.32 0.22 0.29 -0.14 0.17 -1.08 -1.55 -1.87

EIKO Lifesciences Cash Flow Screener - Liquidity Fundamentals

Screen EIKO cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹2, and net cash flow was an inflow of ₹2.

Over the same period, investing activities used ₹9 and financing activities provided ₹8.

Item 2026-March 2025-March 2020-March 2019-March 2018-March 2017-March

Cash from Operations and Investing

Operating Activities 2 3 0 0 0 0
Investing Activities -9 -11 -1 0 0 0

Financing and Net Cash

Financing Activities 8 7 1 -1 0 0
Net Cash Flow 2 -2 0 -1 0 0

EIKO Lifesciences Shareholding Pattern Screener

See EIKO Lifesciences shareholding pattern with promoter, FII, and DII holdings. Check EIKO Lifesciences promoter holding and ownership changes for EIKO on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Feb, promoters held 39.91%, foreign institutions 0.00%, domestic institutions 0.00% and the public 41.65%, spread across 3,028 shareholders.

The shareholder count was 3,028 in 2026-Feb, compared with 2,969 in 2026-Mar.

Item 2026-Feb 2026-Mar 2026-Jun 2026-Sept 2025-Jan 2025-Mar 2025-Jun 2025-Aug

Promoter Holding

Promoter Holding 39.91% 39.91% 39.91% 39.96% 31.27% 36.23% 36.74% 37.11%

Institutional Investors

FII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 41.65% 41.69% 42.34% 41.31% 44.82% 44.38% 44.35% 43.49%
Other Holding 18.44% 18.41% 17.76% 18.72% 23.91% 19.39% 18.91% 19.40%
Shareholder Count 3,028 2,969 3,019 2,998 3,565 3,336 3,322 3,203

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by EIKO Lifesciences. EIKO Lifesciences dividend yield can be compared with peers and other stocks in the market.

No dividends declared by EIKO Lifesciences.

EIKO Lifesciences Stock Index Membership - Nifty & Sensex

See which indices include EIKO Lifesciences stock. Check EIKO index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

EIKO Lifesciences is not part of any tracked indices.
Only major market indices are tracked in our system.

EIKO Lifesciences Market Events Screener - Corporate Actions

Get EIKO Lifesciences corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check EIKO Lifesciences stock events that may affect EIKO share price, along with derivatives, futures and options activity and sector gainers.

15 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated November 5, 2026, with a record date of November 5, 2026.

It is followed by Annual General Meeting dated September 22, 2026 and Quarterly Result Announcement dated August 12, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-11-05 2026-11-05 Quarterly Result Announcement NA 0.18%
2026-09-22 2026-09-22 Annual General Meeting NA -5.47%
2026-08-12 2026-08-12 Quarterly Result Announcement NA -0.04%
2026-05-26 2026-05-26 Quarterly Result Announcement NA 0.67%
2026-01-29 2026-01-29 Quarterly Result Announcement NA -6.23%
2026-01-07 2026-01-07 Extraordinary General Meeting NA 0.53%
2025-10-31 2025-10-31 Quarterly Result Announcement NA 1.80%
2025-09-05 2025-09-05 Annual General Meeting NA -0.87%
2025-07-29 2025-07-29 Quarterly Result Announcement NA -4.48%
2025-05-14 2025-05-14 Quarterly Result Announcement NA -0.10%
2025-02-12 2025-02-12 Quarterly Result Announcement NA -15.01%
2024-10-19 2024-10-19 Quarterly Result Announcement NA -6.07%
2024-09-28 2024-09-28 Annual General Meeting NA 0.68%
2023-07-07 2023-07-07 Rights 2:3 10.17%
2021-03-01 2021-03-01 Change Of Name NA 0.00%

EIKO Lifesciences Competitors Screener - Peer Stocks Comparison

Screen EIKO competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Chemicals sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Solar Industries 169,524 72.90 9,966 30.94% 1,737 44.89
Pidilite Industries 156,723 57.90 14,867 11.05% 2,471 53.93
SRF 73,137 32.00 15,894 7.20% 1,835 54.24
Linde 57,989 119.30 2,549 -0.17% 549 70.98
Gujarat Fluorochemicals 52,246 80.20 5,126 5.63% 574 63.06
Navin Fluorine International 50,238 55.60 3,379 41.21% 664 72.16
Himadri Speciality Chemical 28,317 32.20 4,832 3.60% 755 40.00
Aether Industries 22,231 87.10 1,181 34.17% 220 53.10
Deepak Nitrite 21,483 20.50 7,947 -5.01% 551 55.44
Deepak Fertilisers & Petrochemicals 17,964 14.70 11,609 12.11% 739 63.82

EIKO Lifesciences Company Announcements - News & Reports Screener

Screen EIKO latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated November 17, 2026.

The next most recent announcements are dated November 6, 2026 and November 5, 2026.

Date Update Actions
2026-11-17 Announcement under Regulation 30 (LODR)-Restructuring -
2026-11-06 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-11-05 Announcement under Regulation 30 (LODR)-Restructuring -
2026-11-05 Board Meeting Outcome for Outcome Of The Board Meeting Held Today I.E. On Thursday 05Th November 2026. -
2026-11-02 Board Meeting Intimation for Approval Of Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Half Year Ended On 30Th September 2026. -
2026-10-19 Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 -
2026-10-16 Announcement under Regulation 30 (LODR)-Allotment -
2026-10-12 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-09-24 Closure of Trading Window -
2026-09-23 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2026-09-22 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2026-08-27 Compliance Under Regulation 36 Of The SEBI (Listing Obligations And Disclosures Requirements) Regulations 2015 (The Listing Regulations) -
2026-08-25 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-08-24 Reg. 34 (1) Annual Report. -
2026-08-24 49Th Annual General Meeting Of The Company Will Be Held On Tuesday 22Nd Day Of September 2026 At 04:00 P.M. (IST) Through Video Conferencing/ Other Audio Visual Means. -
2026-08-24 Announcement under Regulation 30 (LODR)-Resignation of Director -
2026-08-24 Announcement under Regulation 30 (LODR)-Change in Management -
2026-08-24 Board Meeting Outcome for Outcome Of The Board Meeting Held On Monday 24Th August 2026 -
2026-08-18 Announcement Under Regulation 30 Of SEBI (LODR) Regulations 2015 -
2026-08-18 Announcement under Regulation 30 (LODR)-Allotment -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹49.68, within a 52-week range of ₹43.87 to ₹55.48. The P/E ratio is 12.40 and the P/B ratio is 1.02, with earnings per unit of ₹3.26. Market capitalisation stands at ₹74.71 Cr. The company operates in the Chemicals sector, in the Chemicals & Petrochemicals industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the BSE. Key statistics were last updated on November 20, 2026. This page covers 5 balance sheet periods, 15 income statement periods, 6 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.